Company Filing History:
Years Active: 1989-1991
Title: Heimo Riedel: Innovator in Hybrid Receptor Technology
Introduction
Heimo Riedel is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of receptor technology, particularly in the development of hybrid receptors. With a total of 2 patents, Riedel's work has advanced the understanding of ligand interactions and their applications in biological assays.
Latest Patents
Riedel's latest patents include innovative designs for hybrid receptors that enhance the determination of ligands and their antagonists. The first patent focuses on hybrid receptors that consist of a ligand binding domain from a predetermined receptor combined with a heterologous reporter polypeptide. This design allows for convenient and large-scale assays of biologically active ligands, antagonists, or agonists. The second patent mirrors this concept, further emphasizing the utility of hybrid receptors in biological research.
Career Highlights
Heimo Riedel is currently associated with Genentech, Inc., a leading biotechnology company. His work at Genentech has positioned him at the forefront of receptor technology, contributing to advancements in drug discovery and development. Riedel's expertise in hybrid receptors has made a significant impact on the field, showcasing his innovative approach to solving complex biological challenges.
Collaborations
Riedel has collaborated with esteemed colleagues such as Thomas J Dull and Axel Ullrich. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of research and innovation in receptor technology.
Conclusion
Heimo Riedel's contributions to hybrid receptor technology exemplify his commitment to advancing scientific knowledge and innovation. His patents and work at Genentech highlight the importance of collaboration and creativity in the field of biotechnology.